Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

Dizal will market sunvozertinib in the US under the Zegfrovy brand name, entering a market for EGFR inhibitors currently ...

As the head of HHS, Kennedy said his federal department is undergoing an “AI revolution.” He implored viewers to “stop ...